To demonstrate the potential application of this MMP sensing method in clinical scenarios, the proposed sensing platform based on SERS was applied to quantify five MMPs (MMP-1, MMP-2, MMP-3, MMP-7 and MMP-9) in human peripheral blood samples from 30 NPC patients. This evidence concerns the gene MMP9 and nasopharyngeal carcinoma.